DrugDashboards

Magnesium Oxide

Magnesium Oxide · MAGNESIUM OXIDE 400 mg/1 · Tablet · Oral · Westminster Pharmaceuticals, LLC

NDC 69367-0298-20 · 120 TABLET in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0347 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04$0.06Nov 2020Sep 2026$0.0347
71 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$1.04
#90 count
$3.12

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$399,734
42,014 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for magnesium oxide (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
M001
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Magnesium Oxide (Tablet)

LabelerStrengthFirst seenLast seen
Aphena Pharma Solutions - Tennessee, LLCMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Apnar Pharma LpMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Belleview Bioscience LLCMAGNESIUM OXIDE 400 mg/400mgJul 15, 2026Sep 2, 2026
Belleview BiosciencesMAGNESIUM OXIDE 241.3 mg/1000mgJul 15, 2026Sep 2, 2026
Endo USAMAGNESIUM OXIDE 253 mg/1Jul 15, 2026Sep 2, 2026
Endo USAMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Kesin PharmaMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals IncMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals Inc.MAGNESIUM OXIDE 420 mg/1Jul 15, 2026Sep 2, 2026
Method Pharmaceuticals, LLCMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Richmond Pharmaceuticals, Inc.MAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026
Richmond Pharmaceuticals, Inc.MAGNESIUM OXIDE 420 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCMAGNESIUM OXIDE 400 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Magnesium Oxide — NDC 69367-0298-20," retrieved September 3, 2026, https://drugdashboards.com/drug/69367029820.

Free to cite with attribution — see how the data is put together.